Early research (Phase 1)Study completedNCT02574663
What this trial is testing
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Who this might be right for
Pancreatic CancerColorectal CancerRectal Cancer+3 more
TG Therapeutics, Inc. 66